| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3200396 | Journal of Allergy and Clinical Immunology | 2009 | 7 Pages |
Abstract
The timing of carboplatin ST in relation to initial HSR is vital for risk stratification and subsequent desensitization. Initial STâ patients with a remote history of HSR are at high risk for conversion to ST+ and can develop more severe HSR.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Paul E. MD, Aleena MD, Eyal MD, Richard T. MD, Carolyn N. MD, Michael V. MD, Johnson T. MD,